SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001516551-24-000032
Filing Date
2024-03-04
Accepted
2024-03-04 16:18:23
Documents
2
Period of Report
2024-02-29

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1709586825.html 3  
1 FORM 3 wk-form3_1709586825.xml 3 1615
2 EX-24 a240229_skyexajxpoa.htm EX-24 5930
  Complete submission text file 0001516551-24-000032.txt   9303
Mailing Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130
Business Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130 (858) 410-0266
Skye Bioscience, Inc. (Issuer) CIK: 0001516551 (see all company filings)

IRS No.: 450692882 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ARDELYX, INC. 34715 ARDENWOOD BLVD, SUITE 100 FREMONT CA 94555
Business Address
Jenkins Annalisa (Reporting) CIK: 0001639481 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-55136 | Film No.: 24715190